✦ LIBER ✦

Molecular diagnostics: an FDA perspective

✍ Scribed by Ardekani, Ali M; Petricoin III, Emanuel F; Hackett, Joseph L

Book ID: 118742696
Publisher: Expert Reviews
Year: 2003
Tongue: English
Weight: 137 KB
Volume: 3
Category: Article
ISSN: 1473-7159
DOI: 10.1586/14737159.3.2.129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA Perspective on Companion Diagnostics

FDA Perspective on Companion Diagnostics: An Evolving Paradigm

✍ Mansfield, E. A. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 198 KB

Molecular diagnostics: A historical pers

Molecular diagnostics: A historical perspective

✍ Gregory J. Tsongalis; Lawrence M. Silverman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Molecular Diagnostics || An Historical P

Molecular Diagnostics || An Historical Perspective on the Clinical Diagnostic Laboratory

✍ Coleman, William B.; Tsongalis, Gregory J. 📂 Article 📅 2006 🏛 Humana Press ⚖ 267 KB

Molecular diagnostics of gliomas: the cl

Molecular diagnostics of gliomas: the clinical perspective

✍ Ghazaleh Tabatabai; Roger Stupp; Martin J. van den Bent; Monika E. Hegi; Jörg C. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 318 KB

US FDA and personalized medicine: in vit

US FDA and personalized medicine: in vitro diagnostic regulatory perspective

✍ Težak, Živana; Kondratovich, Marina V; Mansfield, Elizabeth 📂 Article 📅 2010 🏛 Future Medicine 🌐 English ⚖ 593 KB

Predicting Drug–Drug Interactions: An FD

Predicting Drug–Drug Interactions: An FDA Perspective

✍ Lei Zhang; Yuanchao (Derek) Zhang; Ping Zhao; Shiew-Mei Huang 📂 Article 📅 2009 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 155 KB